Parameter
| Biomarker | OR2A1-AS1 | Full name | OR2A1 antisense RNA 1 | Molecular Type | Nucleic acid |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Prognosis | ||
| Disease | NHL | Disease Subtypes | / | ||
| Organ | Lymphoid tissue | Test Sample / Technology Platform | Organizations (QRT-PCR, GEO analysis) | ||
| Pathobiological Mechanisms | Low expression is associated with poor prognosis, particularly in the germinal center B-cell-like subtype. | ||||
| Clinical Availability Status | Research validation phase: Supported by data from 98 patients and database analysis, requires prospective validation, and tissue testing is invasive. | ||||
| Notes and Dynamics | Exploring blood sample testing methods to establish a multi-marker prognostic model. | ||||